What is Danaher's life sciences — impairment charges, after tax?

Danaher (DHR) reported life sciences — impairment charges, after tax of $328.00M in Q2 2025.

What does life sciences — impairment charges, after tax mean?

The after-tax cost recognized when the value of an asset is written down because it is no longer worth its original book value.

Business Segments · Impairment charges, after tax

Life Sciences — Impairment charges, after tax

Danaher Life Sciences — Impairment charges, after tax increased by 94.1% to $328.00M in Q2 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment

CategoryProfitability

SignalLower is better

VolatilityModerate

First reportedQ3 2024

Last reportedQ2 2025

How to read this metric

An increase suggests declining asset performance or a deterioration in the business outlook for the specific segment.

Detailed definition

This metric represents the after-tax reduction in the carrying value of assets, such as long-lived assets or intangible...

Peer comparison

Comparable to 'Asset Impairment Charges' reported by peers in the life sciences and industrial sectors.

Metric ID: dhr_segment_life_sciences_impairment_charges_after_tax

Historical Data

2 periods

	Q3 '24	Q2 '25
Value	$169.00M	$328.00M
QoQ Change	—	+94.1%

Range$169.00M – $328.00M

Similar Metrics at Other Companies

Exxon MobilXOM View metric

EnbridgeENB View metric

Vertex PharmaceuticalsVRTX View metric

NewmontNEM View metric

International Business MachinesIBM View metric

Frequently Asked Questions

What is Danaher's life sciences — impairment charges, after tax?: Danaher (DHR) reported life sciences — impairment charges, after tax of $328.00M in Q2 2025.
What does life sciences — impairment charges, after tax mean?: The after-tax cost recognized when the value of an asset is written down because it is no longer worth its original book value.